The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege
Open accessAbstract
The eye is a privileged site that cannot tolerate destructive inflammatory responses. Inflammatory cells entering the anterior chamber of the eye in response to viral infection underwent apoptosis that was dependent on Fas (CD95)-Fas ligand (FasL) and produced no tissue damage. In contrast, viral infection in gld mice, which lack functional FasL, resulted in an inflammation and invasion of ocular tissue without apoptosis. Fas-positive but not Fas-negative tumor cells were killed by apoptosis when placed within isolated anterior segments of the eyes of normal but not FasL-negative mice. FasL messenger RNA and protein were detectable in the eye. Thus, Fas-FasL interactions appear to be an important mechanism for the maintenance of immune privilege.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444
Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A., & Nagata, S. (1992) · Nature · doi:10.1038/356314a0 · Cited by 2,885
Suda, T., Takahashi, T., Golstein, P., & Nagata, S. (1993) · Cell · doi:10.1016/0092-8674(93)90326-l · Cited by 2,489
Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand
Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T., & Nagata, S. (1994) · Cell · doi:10.1016/0092-8674(94)90375-1 · Cited by 1,528
Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation
Ju, S.-T., Panka, D. J., Cui, H., Ettinger, R., EI-Khatib, M., Sherr, D. H., Stanger, B. Z., & Marshak-Rothstein, A. (1995) · Nature · doi:10.1038/373444a0 · Cited by 1,499
Brunner, T., Mogil, R. J., LaFace, D., Yoo, N. J., Mahboubi, A., Echeverri, F., Martin, S. J., Force, W. R., Lynch, D. H., Ware, C. F., et al. (1995) · Nature · doi:10.1038/373441a0 · Cited by 1,314
Self-citationSmith, C. A., Williams, G. T., Kingston, R., Jenkinson, E. J., & Owen, J. J. T. (1989) · Nature · doi:10.1038/337181a0 · Cited by 1,133
Medawar, P. B. (1948) · PubMed · Cited by 1,109
Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity.
Rouvier, E., Luciani, M. F., & Golstein, P. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.1.195 · Cited by 787
Singer, G. G., & Abbas, A. K. (1994) · Immunity · doi:10.1016/1074-7613(94)90067-1 · Cited by 691
Cited by
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K., et al. (2002) · Nature Medicine · doi:10.1038/nm730 · Cited by 5,025
Nagata, S. (1997) · Cell · doi:10.1016/s0092-8674(00)81874-7 · Cited by 4,938
Signalling pathways of the TNF superfamily: a double-edged sword
Aggarwal, B. B. (2003) · Nature Reviews Immunology · doi:10.1038/nri1184 · Cited by 2,793
Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.
Walczak, H., Miller, R. E., Ariail, K., Gliniak, B., Griffith, T. S., Kubin, M., Chin, W., Jones, J., Woodward, A., Le, T., et al. (1999) · Nature Medicine · doi:10.1038/5517 · Cited by 2,497
Self-citationMelanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape
Hahne, M., Rimoldi, D., Schröter, M., Romero, P., Schreier, M., French, L. E., Schneider, P., Bornand, T., Fontana, A., Lienard, D., et al. (1996) · Science · doi:10.1126/science.274.5291.1363 · Cited by 1,249
TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL
Walczak, H. (1997) · The EMBO Journal · doi:10.1093/emboj/16.17.5386 · Cited by 1,130
The molecular basis of retinal ganglion cell death in glaucoma
Almasieh, M., Wilson, A. M., Morquette, B., Cueva Vargas, J. L., & Di Polo, A. (2012) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.11.002 · Cited by 971
The many roles of FAS receptor signaling in the immune system
Strasser, A., Jost, P. J., & Nagata, S. (2009) · Immunity · doi:10.1016/j.immuni.2009.01.001 · Cited by 968
Fundamental Mechanisms of Regulated Cell Death and Implications for Heart Disease
Del Re, D. P., Amgalan, D., Linkermann, A., Liu, Q., & Kitsis, R. N. (2019) · Physiological Reviews · doi:10.1152/physrev.00022.2018 · Cited by 961
MATURE T LYMPHOCYTE APOPTOSIS—Immune Regulation in a Dynamic and Unpredictable Antigenic Environment
Lenardo, M., Chan, F. K.-M., Hornung, F., McFarland, H., Siegel, R., Wang, J., & Zheng, L. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.221 · Cited by 943
REGULATION OF IMMUNE RESPONSES THROUGH INHIBITORY RECEPTORS
Long, E. O. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.875 · Cited by 939
Nagata, S. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4834 · Cited by 905
Strand, S., Hofmann, W. J., Hug, H., Müller, M., Otto, G., Strand, D., Mariani, S. M., Stremmel, W., Krammer, P. H., & Galle, P. R. (1996) · Nature Medicine · doi:10.1038/nm1296-1361 · Cited by 897
p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs
Müller, M., Wilder, S., Bannasch, D., Israeli, D., Lehlbach, K., Li-Weber, M., Friedman, S. L., Galle, P. R., Stremmel, W., Oren, M., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.11.2033 · Cited by 878
The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand.
O'Connell, J., O'Sullivan, G. C., Collins, J. K., & Shanahan, F. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.1075 · Cited by 878
Schneider, P., Holler, N., Bodmer, J.-L., Hahne, M., Frei, K., Fontana, A., & Tschopp, J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.8.1205 · Cited by 812
Ocular immune privilege: therapeutic opportunities from an experiment of nature
Streilein, J. W. (2003) · Nature Reviews Immunology · doi:10.1038/nri1224 · Cited by 807
Flow cytometry of apoptotic cell death
Vermes, I., Haanen, C., & Reutelingsperger, C. (2000) · Journal of Immunological Methods · doi:10.1016/s0022-1759(00)00233-7 · Cited by 789
Nagata, S. (1999) · Annual Review of Genetics · doi:10.1146/annurev.genet.33.1.29 · Cited by 779
T he P athogenesis of O ral L ichen P lanus
Sugerman, P. B., Savage, N. W., Walsh, L. J., Zhao, Z. Z., Zhou, X. J., Khan, A., Seymour, G. J., & Bigby, M. (2002) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/154411130201300405 · Cited by 768
Apoptosis and cancer: the genesis of a research field
Cotter, T. G. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2663 · Cited by 758
Downregulation of Fas ligand by shedding
Tanaka, M., Itai, T., Adachi, M., & Nagata, S. (1998) · Nature Medicine · doi:10.1038/nm0198-031 · Cited by 669
The Regulatory Role of Vα14 NKT Cells in Innate and Acquired Immune Response
Taniguchi, M., Harada, M., Kojo, S., Nakayama, T., & Wakao, H. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141057 · Cited by 669
Tanaka, M., Suda, T., Haze, K., Nakamura, N., Sato, K., Kimura, F., Motoyoshi, K., Mizuki, M., Tagawa, S., Ohga, S., et al. (1996) · Nature Medicine · doi:10.1038/nm0396-317 · Cited by 666
Intracellular Regulation of TRAIL-Induced Apoptosis in Human Melanoma Cells
Griffith, T. S., Chin, W. A., Jackson, G. C., Lynch, D. H., & Kubin, M. Z. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.6.2833 · Cited by 664
Self-citationInflammation and its role in age-related macular degeneration
Kauppinen, A., Paterno, J. J., Blasiak, J., Salminen, A., & Kaarniranta, K. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2147-8 · Cited by 649
Activation‐induced cell death in T cells
Green, D. R., Droin, N., & Pinkoski, M. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00051.x · Cited by 647
Self-citationA subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis.
Süss, G., & Shortman, K. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1789 · Cited by 631
Cloning and Characterization of TRAIL-R3, a Novel Member of the Emerging TRAIL Receptor Family
Degli-Esposti, M. A., Smolak, P. J., Walczak, H., Waugh, J., Huang, C.-P., DuBose, R. F., Goodwin, R. G., & Smith, C. A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.7.1165 · Cited by 629
Autoimmune disease: why and where it occurs
Marrack, P., Kappler, J., & Kotzin, B. L. (2001) · Nature Medicine · doi:10.1038/90935 · Cited by 609
Potential Involvement of Fas and Its Ligand in the Pathogenesis of Hashimoto's Thyroiditis
Giordano, C., Stassi, G., De Maria, R., Todaro, M., Richiusa, P., Papoff, G., Ruberti, G., Bagnasco, M., Testi, R., & Galluzzo, A. (1997) · Science · doi:10.1126/science.275.5302.960 · Cited by 582
Environmentally Controlled Invasion of Cancer Cells by Engineered Bacteria
Anderson, J. C., Clarke, E. J., Arkin, A. P., & Voigt, C. A. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.10.076 · Cited by 572
Obstructive nephropathy and renal fibrosis
Klahr, S., & Morrissey, J. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00362.2001 · Cited by 555
The Role of Apoptosis in Age-Related Macular Degeneration
Dunaief, J. L. (2002) · Archives of Ophthalmology · doi:10.1001/archopht.120.11.1435 · Cited by 525
Inhibition of Fas death signals by FLIPs
Tschopp, J., Irmler, M., & Thome, M. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80223-9 · Cited by 520
The Fas System Is a Key Regulator of Germ Cell Apoptosis in the Testis*
Lee, J., Richburg, J. H., Younkin, S. C., & Boekelheide, K. (1997) · Endocrinology · doi:10.1210/endo.138.5.5110 · Cited by 519
Differential Effects of Cytolytic T Cell Subsets on Intracellular Infection
Stenger, S., Mazzaccaro, R. J., Uyemura, K., Cho, S., Barnes, P. F., Rosat, J.-P., Sette, A., Brenner, M. B., Porcelli, S. A., Bloom, B. R., et al. (1997) · Science · doi:10.1126/science.276.5319.1684 · Cited by 519
Apoptosis: a mechanism of acute and chronic liver injury
Guicciardi, M. E., & Gores, G. J. (2005) · Gut · doi:10.1136/gut.2004.053850 · Cited by 514
Suda, T., Hashimoto, H., Tanaka, M., Ochi, T., & Nagata, S. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.12.2045 · Cited by 508
To Die or Not to Die: An Overview of Apoptosis and Its Role in Disease
Hetts, S. W. (1998) · JAMA · doi:10.1001/jama.279.4.300 · Cited by 507
Death receptors in chemotherapy and cancer
Debatin, K.-M., & Krammer, P. H. (2004) · Oncogene · doi:10.1038/sj.onc.1207558 · Cited by 505
The TNF Family of Ligands and Receptors: Communication Modules in the Immune System and Beyond
Dostert, C., Grusdat, M., Letellier, E., & Brenner, D. (2019) · Physiological Reviews · doi:10.1152/physrev.00045.2017 · Cited by 498
The Role of Fas in Autoimmune Diabetes
Chervonsky, A. V., Wang, Y., Wong, F. S., Visintin, I., Flavell, R. A., Janeway, C. A., & Matis, L. A. (1997) · Cell · doi:10.1016/s0092-8674(00)80178-6 · Cited by 496
Trautmann, A., Akdis, M., Kleemann, D., Altznauer, F., Simon, H.-U., Graeve, T., Noll, M., Bröcker, E.-B., Blaser, K., & Akdis, C. A. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9199 · Cited by 495
Monocyte-mediated Tumoricidal Activity via the Tumor Necrosis Factor–related Cytokine, TRAIL
Griffith, T. S., Wiley, S. R., Kubin, M. Z., Sedger, L. M., Maliszewski, C. R., & Fanger, N. A. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.8.1343 · Cited by 476
Self-citationImmune escape of tumors: apoptosis resistance and tumor counterattack
Igney, F. H., & Krammer, P. H. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.6.907 · Cited by 468
Aragane, Y., Kulms, D., Metze, D., Wilkes, G., Pöppelmann, B., Luger, T. A., & Schwarz, T. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.1.171 · Cited by 463
Myc pathways provoking cell suicide and cancer
Nilsson, J. A., & Cleveland, J. L. (2003) · Oncogene · doi:10.1038/sj.onc.1207261 · Cited by 462
Kamradt, T., & Mitchison, N. A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103013440907 · Cited by 457
Kang, S.-M., Schneider, D. B., Lin, Z., Hanahan, D., Dichek, D. A., Stock, P. G., & Baekkeskov, S. (1997) · Nature Medicine · doi:10.1038/nm0797-738 · Cited by 450
French, L. E., Hahne, M., Viard, I., Radlgruber, G., Zanone, R., Becker, K., Müller, C., & Tschopp, J. (1996) · The Journal of cell biology · doi:10.1083/jcb.133.2.335 · Cited by 448
See no evil, hear no evil, do no evil: the lessons of immune privilege
Niederkorn, J. Y. (2006) · Nature Immunology · doi:10.1038/ni1328 · Cited by 447
Prevention of Islet Allograft Rejection with Engineered Myoblasts Expressing FasL in Mice
Lau, H. T., Yu, M., Fontana, A., & Stoeckert, C. J. (1996) · Science · doi:10.1126/science.273.5271.109 · Cited by 445
Natural Killer Cells and Cancer
(2003) · Advances in Cancer Research · doi:10.1016/s0065-230x(03)90004-2 · Cited by 438
Placental apoptosis in preeclampsia
Allaire, A. (2000) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(00)00895-4 · Cited by 434
The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity
Siegel, R. M., Ka-Ming Chan, F., Chun, H. J., & Lenardo, M. J. (2000) · Nature Immunology · doi:10.1038/82712 · Cited by 431
Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?
Saas, P., Walker, P. R., Hahne, M., Quiquerez, A. L., Schnuriger, V, Perrin, G., French, L., Van Meir, E. G., de Tribolet, N., Tschopp, J., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119273 · Cited by 398
Bossi, G., & Griffiths, G. M. (1999) · Nature Medicine · doi:10.1038/4779 · Cited by 387
NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain
Huang, B., Eberstadt, M., Olejniczak, E. T., Meadows, R. P., & Fesik, S. W. (1996) · Nature · doi:10.1038/384638a0 · Cited by 385
Bacterial Endophthalmitis: Epidemiology, Therapeutics, and Bacterium-Host Interactions
Callegan, M. C., Engelbert, M., Parke, D. W., Jett, B. D., & Gilmore, M. S. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.1.111-124.2002 · Cited by 385
Regulation of the Proinflammatory Effects of Fas Ligand (CD95L)
Chen, J.-J., Sun, Y., & Nabel, G. J. (1998) · Science · doi:10.1126/science.282.5394.1714 · Cited by 383
CD95-Induced Apoptosis of Lymphocytes in an Immune Privileged Site Induces Immunological Tolerance
Griffith, T. S., Yu, X., Herndon, J. M., Green, D. R., & Ferguson, T. A. (1996) · Immunity · doi:10.1016/s1074-7613(00)80305-2 · Cited by 382
Self-citationMühlbauer, M., Fleck, M., Schütz, C., Weiss, T., Froh, M., Blank, C., Schölmerich, J., & Hellerbrand, C. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.05.007 · Cited by 378
Caspase 1-independent IL-1β release and inflammation induced by the apoptosis inducer Fas ligand
Miwa, K., Asano, M., Horai, R., Iwakura, Y., Nagata, S., & Suda, T. (1998) · Nature Medicine · doi:10.1038/3276 · Cited by 373
CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival.
Stuart, P. M., Griffith, T. S., Usui, N., Pepose, J., Yu, X., & Ferguson, T. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119173 · Cited by 367
Self-citationOcular immune privilege: the eye takes a dim but practical view of immunity and inflammation
Streilein, J. W. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.1102574 · Cited by 367
Allison, J., Georgiou, H. M., Strasser, A., & Vaux, D. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3943 · Cited by 366
Oehen, S., & Brduscha-Riem, K. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.10.5338 · Cited by 365
The human hair follicle immune system: cellular composition and immune privilege
Christoph, T., Müller-Röver, S., Audring, H., Tobin, D. J., Hermes, B., Cotsarelis, G., Rückert, R., & Paus, R. (2000) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2000.03464.x · Cited by 360
Apoptosis: Programmed cell death at a molecular level
Schultz, D. R., & Harringto, W. J. (2003) · Seminars in Arthritis and Rheumatism · doi:10.1053/sarh.2003.50005 · Cited by 356
Sonoda, K.-H., Exley, M., Snapper, S., Balk, S. P., & Stein-Streilein, J. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.9.1215 · Cited by 354
Stromal-epithelial interactions in the cornea
Wilson, S. E., Liu, J. J., & Mohan, R. R. (1999) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(98)00017-2 · Cited by 345
Yang, O. O., Kalams, S. A., Trocha, A., Cao, H., Luster, A., Johnson, R. P., & Walker, B. D. (1997) · Journal of Virology · doi:10.1128/jvi.71.4.3120-3128.1997 · Cited by 340
Ocular surface immunity: Homeostatic mechanisms and their disruption in dry eye disease
Barabino, S., Chen, Y., Chauhan, S., & Dana, R. (2012) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2012.02.003 · Cited by 339
Bennett, M. W., O’Connell, J., O’Sullivan, G. C., Brady, C., Roche, D., Collins, J. K., & Shanahan, F. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.11.5669 · Cited by 326
Cell death induced by the Fas/Fas ligand pathway and its role in pathology
Waring, P., & Müllbacher, A. (1999) · Immunology & Cell Biology · doi:10.1046/j.1440-1711.1999.00837.x · Cited by 322
Arsenic carcinogenesis in the skin
Yu, H.-S., Liao, W.-T., & Chai, C.-Y. (2006) · Journal of Biomedical Science · doi:10.1007/s11373-006-9092-8 · Cited by 318
Nitric Oxide Inhibits Fas-induced Apoptosis
Mannick, J. B., Miao, X. Q., & Stamler, J. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.39.24125 · Cited by 315
Antitumor effect of locally produced CD95 ligand
Seino, K.-I., Kayagaki, N., Okumura, K., & Yagita, H. (1997) · Nature Medicine · doi:10.1038/nm0297-165 · Cited by 312
Taylor, D. L., Jones, F., Kubota, E. S. F. C. S., & Pocock, J. M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4456-04.2005 · Cited by 308
Panda, A., Vanathi, M., Kumar, A., Dash, Y., & Priya, S. (2007) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2007.04.008 · Cited by 306
Viruses, Immunity, and Cancer: Lessons from Hepatitis B
Chisari, F. V. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64980-2 · Cited by 304
Uveitis: A Potentially Blinding Disease
Durrani, O. M., Meads, C. A., & Murray, P. I. (2004) · Ophthalmologica · doi:10.1159/000078612 · Cited by 304
Qian, S., Lu, L., Fu, F., Li, Y., Li, W., Starzl, T. E., Fung, J. J., & Thomson, A. W. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.10.4654 · Cited by 302
Inhibition of T–Cell Responses by Hepatic Stellate Cells Via B7–H1-Mediated T–Cell Apoptosis in Mice
Yu, M., Chen, C., Liang, X., Wang, L., Gandhi, C. R., Fung, J. J., Lu, L., & Qian, S. (2004) · Hepatology · doi:10.1002/hep.20488 · Cited by 301
Immunosuppressive Factors Secreted by Human Amniotic Epithelial Cells
Li, H., Niederkorn, J. Y., Neelam, S., Mayhew, E., Word, R. A., McCulley, J. P., & Alizadeh, H. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-0495 · Cited by 299
Fändrich, F., Lin, X., Chai, G. X., Schulze, M., Ganten, D., Bader, M., Holle, J., Huang, D.-S., Parwaresch, R., Zavazava, N., et al. (2002) · Nature Medicine · doi:10.1038/nm0202-171 · Cited by 296
Alopecia areata: a review of disease pathogenesis
Rajabi, F., Drake, L. A., Senna, M. M., & Rezaei, N. (2018) · British Journal of Dermatology · doi:10.1111/bjd.16808 · Cited by 296
Streilein, J. W. (1995) · Science · doi:10.1126/science.270.5239.1158 · Cited by 295
Adler, A. J., Marsh, D. W., Yochum, G. S., Guzzo, J. L., Nigam, A., Nelson, W. G., & Pardoll, D. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.10.1555 · Cited by 294
Wesselborg, S., Engels, I. H., Rossmann, E., Los, M., & Schulze-Osthoff, K. (1999) · Blood · doi:10.1182/blood.v93.9.3053 · Cited by 292
Indolamine 2,3‐dioxygenase is expressed in the CNS and down‐regulates autoimmune inflammation
Kwidzinski, E., Bunse, J., Aktas, O., Richter, D., Mutlu, L., Zipp, F., Nitsch, R., & Bechmann, I. (2005) · The FASEB Journal · doi:10.1096/fj.04-3228fje · Cited by 289
Autoimmune thyroid disease: new models of cell death in autoimmunity
Stassi, G., & De Maria, R. (2002) · Nature Reviews Immunology · doi:10.1038/nri750 · Cited by 284
The role of Fas ligand in immune privilege
Green, D. R., & Ferguson, T. A. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35103104 · Cited by 284
Self-citationSensitization of Cancer Cells Treated With Cytotoxic Drugs to Fas-Mediated Cytotoxicity
Micheau, O., Solary, E., Hammann, A., Martin, F., & Dimanche-Boitrel, M.-T. (1997) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/89.11.783 · Cited by 281
Darnell, R. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4529 · Cited by 279
PROTEOLYTIC ACTIVITIES THAT MEDIATE APOPTOSIS
Kidd, V. J. (1998) · Annual Review of Physiology · doi:10.1146/annurev.physiol.60.1.533 · Cited by 277
Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain.
Dowling, P., Shang, G., Raval, S., Menonna, J., Cook, S., & Husar, W. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.4.1513 · Cited by 273
The immunology of successful pregnancy
Veenstra van Nieuwenhoven, A. L. (2003) · Human Reproduction Update · doi:10.1093/humupd/dmg026 · Cited by 273
Fas ligand/Fas system in the brain: regulator of immune and apoptotic responses
Choi, C., & Benveniste, E. N. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2003.08.007 · Cited by 270
Metadata
- Authors
- Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R., & Ferguson, T. A.
- Venue
- Science
- Published
- 1995-11-17
- Volume
- 270
- Issue
- 5239
- Pages
- 1189-1192
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1978018492
- Cited by
- 2,005
- References
- 20
- FWCI
- 42.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.